Joshua DeLeon

1.1k total citations · 1 hit paper
20 papers, 772 citations indexed

About

Joshua DeLeon is a scholar working on Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joshua DeLeon has authored 20 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joshua DeLeon's work include Atherosclerosis and Cardiovascular Diseases (5 papers), Systemic Lupus Erythematosus Research (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Joshua DeLeon is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (5 papers), Systemic Lupus Erythematosus Research (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Joshua DeLeon collaborates with scholars based in United States. Joshua DeLeon's co-authors include Allison B. Reiss, Lora J. Kasselman, Heather A. Renna, Nicholas A. Vernice, Priya Agarwala, Peter Spiegler, Daniel S. Glass, Steven E. Carsons, Thomas Palaia and Radmila Lyubarova and has published in prestigious journals such as Journal of the American College of Cardiology, Atherosclerosis and Experimental Biology and Medicine.

In The Last Decade

Joshua DeLeon

20 papers receiving 755 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Idiopathic pulmonary fibrosis: Current and future treatment

2022 175 citations Daniel S. Glass, Heather A. Renna et al. The Clinical Respiratory Journal profile →

Peers

Countries citing papers authored by Joshua DeLeon

Since Specialization

Citations

This map shows the geographic impact of Joshua DeLeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua DeLeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua DeLeon more than expected).

Fields of papers citing papers by Joshua DeLeon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua DeLeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua DeLeon. The network helps show where Joshua DeLeon may publish in the future.

Co-authorship network of co-authors of Joshua DeLeon

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua DeLeon. A scholar is included among the top collaborators of Joshua DeLeon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua DeLeon. Joshua DeLeon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Idiopathic pulmonary fibrosis: Current and future treatment breakdown → 2022 ·The Clinical Respiratory Journal ·Daniel S. Glass, (unknown), Heather A. Renna, Priya Agarwala, Peter Spiegler, Joshua DeLeon, Allison B. Reiss	175
2	Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention 2021 ·Inflammation ·Allison B. Reiss, (unknown), Saba Ahmed, Steven E. Carsons, Joshua DeLeon	31
3	Effect of oxytocin on lipid accumulation under inflammatory conditions in human macrophages 2021 ·Experimental and Molecular Pathology ·(unknown), Nicholas A. Vernice, Heather A. Renna, Steven E. Carsons, Joshua DeLeon, Aaron Pinkhasov, Irving H. Gomolin, Daniel S. Glass, Allison B. Reiss, Lora J. Kasselman	1
4	Alzheimer Disease Clinical Trials Targeting Amyloid 2021 ·The Neurologist ·Allison B. Reiss, (unknown), Joshua DeLeon, Aaron Pinkhasov, Irving H. Gomolin, Amy D. Glass, Hirra A. Arain, Mark M. Stecker	21
5	Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches 2020 ·Respiratory Investigation ·Daniel S. Glass, (unknown), Heather A. Renna, Priya Agarwala, Peter Spiegler, Lora J. Kasselman, Amy D. Glass, Joshua DeLeon, Allison B. Reiss	87
6	Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A 2019 ·Inflammation Research ·Iryna Voloshyna, (unknown), Lora J. Kasselman, (unknown), Steven E. Carsons, Joshua DeLeon, Joseph Mattana, Nobuyuki Miyawaki, Allison B. Reiss	14
7	Adenosine and the Cardiovascular System 2019 ·American Journal of Cardiovascular Drugs ·Allison B. Reiss, (unknown), Lora J. Kasselman, Heather A. Renna, Nicholas A. Vernice, (unknown), (unknown), Steven E. Carsons, Joshua DeLeon	84
8	Cholesterol efflux alterations in adolescent obesity: role of adipose-derived extracellular vesical microRNAs 2019 ·Journal of Translational Medicine ·Matthew D. Barberio, Lora J. Kasselman, Martin P. Playford, (unknown), Heather A. Renna, (unknown), Joshua DeLeon, Iryna Voloshyna, (unknown), (unknown), Sarah C. Ferrante, Evan P. Nadler, Nehal N. Mehta, Allison B. Reiss, Robert J. Freishtat	38
9	Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy 2019 ·Medicina ·Allison B. Reiss, Hirra A. Arain, Lora J. Kasselman, Heather A. Renna, Juan Zhen, Iryna Voloshyna, Joshua DeLeon, Steven E. Carsons, Michelle Petri	5
10	The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity 2018 ·Atherosclerosis ·Lora J. Kasselman, Nicholas A. Vernice, Joshua DeLeon, Allison B. Reiss	120
11	PCSK9 in cholesterol metabolism: from bench to bedside 2018 ·Clinical Science ·Allison B. Reiss, (unknown), (unknown), Juan Zhen, (unknown), Lora J. Kasselman, Joshua DeLeon	25
12	Is intra‐procedure three‐dimensional transesophageal echocardiogram an alternative to preprocedure multidetector computed tomography for the measurement of the aortic annulus in patients undergoing transcatheter aortic valve replacement? 2017 ·Echocardiography ·Abdul Moiz Hafiz, Giorgio A. Medranda, Nikolaos Kakouros, (unknown), (unknown), George Gubernikoff, (unknown), (unknown), Joshua DeLeon, Kevin Marzo, Rose Calixte, Juan Gaztañaga	8
13	Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux 2016 ·Experimental Biology and Medicine ·Iryna Voloshyna, (unknown), Michael J. Littlefield, Nicolle Siegart, George K. Turi, Melissa Fazzari, Steven E. Carsons, Joshua DeLeon, Allison B. Reiss	31
14	Inhibition of the Receptor for Advanced Glycation end Products Restores Cholesterol Efflux in thp-1 Human Macrophages Exposed to Plasma from Type 1 Diabetes Mellitus Patients 2016 ·Journal of Investigative Medicine ·(unknown), Siham Accacha, Iryna Voloshyna, Nicolle Siegart, Lora J. Kasselman, (unknown), Joshua DeLeon, (unknown)	1
15	LEFT VENTRICULAR NON-COMPACTION ASSESSED BY CARDIAC MAGNETIC RESONANCE IMAGING IS ASSOCIATED WITH INCREASED VENTRICULAR ARRHYTHMIAS 2014 ·Journal of the American College of Cardiology ·Daniel R. Zakhary, (unknown), (unknown), Abdul Moiz Hafiz, (unknown), Melissa Fazzari, Joshua DeLeon, Kevin Marzo, Juan Gaztañaga, (unknown)	1
16	ATHEROPROTECTIVE EFFECTS OF ADALIMUMAB AND RESVERATROL IN THP-1 HUMAN MACROPHAGES: CHANGES IN EXPRESSION OF PROTEINS INVOLVED IN LIPID EFFLUX 2014 ·Journal of the American College of Cardiology ·Allison B. Reiss, Joshua DeLeon, Steven E. Carsons, Jessica S. Mounessa, Michael J. Littlefield, Iryna Voloshyna	1
17	Impact of first contact on symptom onset–to-door time in patients presenting for primary percutaneous coronary intervention 2013 ·The American Journal of Emergency Medicine ·Abdul Moiz Hafiz, Srihari S. Naidu, Joshua DeLeon, Shahidul Islam, (unknown), (unknown), (unknown), (unknown), Kevin Marzo	8
18	Circulating Endothelial Microparticles in Diabetes Mellitus 2010 ·Mediators of Inflammation ·(unknown), Radmila Lyubarova, (unknown), Thomas Palaia, Joshua DeLeon, Louis Ragolia	106
19	The use of viscoelastometry to determine survival curves for intact genomes. 1984 ·PubMed ·Christopher S. Lange, (unknown), (unknown), Joshua DeLeon, Gary D. Grossman	9
20	The Use of Viscoelastometry to Determine Survival Curves for Intact Genomes 1984 ·Radiation Research ·Christopher S. Lange, (unknown), (unknown), Joshua DeLeon, Gary D. Grossman	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact